Video Interview: Tech Transfer Powered by Dual Site Precision

The best-fit solution for your endeavor - Rentschler Development Services At Rentschler Biopharma, we are committed to being your strategic partner, providing not just solutions but also expert support that empowers your success and contribution to the treatment of serious and rare diseases. We recognize the importance of providing our clients with the best-fit solution to realizing their ideas and projects. Our Rentschler Development Services Program is a comprehensive framework aimed at tailoring development projects to clients’ particular needs and project stages. Our goal is to empower our clients by offering a range of tailored services. Whether you’re a startup or an established player, we understand that one size does not fit all. With the Development Services Program, you can choose from three different options: Velocity, Flexibility, and Liberty. Click to discover more Velocity Velocity is our fast-track service offering for clients who must be fast. With our fixed timelines, fixed prices and standardized processes , we reliably deliver released Drug Substance for your clinical Phase I/II project on-time. Click to discover more Flexibility Sometimes our clients require flexibility due to shifting priorities, unforeseen challenges, or changing market dynamics. Flexibility provides you with customized timelines and ensures that you can pivot, when necessary, without compromising quality independent of the clinical phase . Click to discover more Liberty For our clients who thrive on experimentation and innovation, Liberty offers you standalone activities and work packages to test hypotheses, fill a specific gap in your portfolio, iterate rapidly, and stay ahead of the wave . Click to discover more Interested? Then get in touch with our Business Development team at BIO International Convention or contact us via our website . | Successful tech transfer begins with early alignment, clear scope definition, and proactive risk management to ensure smooth progression from development to GMP manufacturing. By combining global expertise with local execution, we deliver consistent quality, operational flexibility, and reduced risk for clients advancing complex therapies. What to expect in this video interview Henning Gerschewski, our VP of Manufacturing and Technology, and Patrick Cushing, our VP Operations , spoke with Megan Manzano of BioPharm International , about how Rentschler Biopharma leverages a highly coordinated dual site model to streamline tech transfer between sites. Central to this approach is early-stage planning, timeline alignment, and a deep understanding of process robustness. Risk mitigation, too, plays a huge role in identifying differences in equipment, scale, and processes, while defining critical parameters to enable a smooth and reliable transfer. Ultimately, strong communication, experienced project teams, and a commitment to quality and compliance allows us to accelerate timelines while delivering both efficiency and confidence to clients. Key Takeaways Understand the key elements required for a successful tech transfer. Evaluate how dual-site manufacturing models can enhance flexibility, scalability, and consistency in biopharmaceutical production. Identify strategies to accelerate tech transfer timelines while maintaining process, product quality, and regulatory compliance.